Published September 1990
| Version v1
Journal article
Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer
Description
131I continues to be one of the safest and most effective methods of diagnosing and treating metastatic well differentiated thyroid cancer. It is not without risk, however, and must be judiciously applied to carefully prepared and selected patients. 136 references
Additional details
Publishing Information
- Journal Title
- Endocrinology and Metabolism Clinics of North America
- Journal Volume
- 19
- Journal Issue
- 3
- Series
- Endocrinol. Metab. Clin. N. Am.
- Journal Page Range
- 685-718
- ISSN
- 0889-8529
- CODEN
- ECNAE
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 22043475
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE; S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- DIAGNOSIS; IODINE 131; METASTASES; NEOPLASMS; RADIOTHERAPY; REVIEWS; THYROID
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; DAYS LIVING RADIOISOTOPES; DISEASES; DOCUMENT TYPES; ENDOCRINE GLANDS; GLANDS; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPES; MEDICINE; NUCLEI; ODD-EVEN NUCLEI; ORGANS; RADIOISOTOPES; THERAPY